Evaluation of Endostapled Anastomoses for Laparoscopic Gastric Bypass (EEA-LGB) (EEA-LGB)

February 11, 2010 updated by: University of California, Irvine

Evaluation of Endostapled Anastomoses for Laparoscopic Gastric Bypass (EEA-LGB)a Prospective Randomized Comparison of the 3.5 mm vs 4.8 mm Circular Stapler for Creation of the Gastrojejunostomy in Prevention of Staple Line Hemorrhage During Laparoscopic Gastric Bypass

Laparoscopic gastric bypass surgery is a common procedure being performed for the treatment of morbid obesity. The procedure consists of a creation of a small gastric pouch and rerouting the small bowel to bypass the stomach and duodenum. There are two anastomoses in this procedure: the gastrojejunostomy and the jejunojejunostomy. Potential complications after gastric bypass include gastrointestinal bleeding and leaks. Gastrointestinal bleeding can occur at any staple line including the gastrojejunostomy. Potential methods for prevention of postoperative gastrointestinal bleeding include oversewing of the anastomosis or the use of a smaller stapler height. We hypothesize that the use of staplers with smaller staple height will significantly result in a lower rate of staple line bleeding and possible leaks.

Study Overview

Detailed Description

RATIONALE:

  1. Gastrointestinal (GI) bleeding can occur in up to 4% of cases. GI bleeding is associated with significant morbidity which may include transfusion and possible re-operation
  2. Leaks at the gastrojejunostomy can be potentially life threatening and ranged from 1% to 2%.

HYPOTHESES:

The smaller circular stapler may be associated with a lower rate of intraoperative intraluminal bleeding and postoperative gastrointestinal bleeding than the larger one.

Study Type

Interventional

Enrollment (Actual)

355

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • California
      • Orange, California, United States, 92868
        • University of California, Irvine Medical Center
    • Florida
      • Tampa, Florida, United States, 33601
        • Tampa General Hospital- University of South Florida
    • Massachusetts
      • Boston, Massachusetts, United States, 02215
        • Beth Israel Deaconess Medical Center
    • New York
      • New York, New York, United States, 10021
        • New York Presbyterian Hospital-Weill Cornell Medical Center
    • Ohio
      • Columbus, Ohio, United States, 43210-1228
        • Ohio State University
    • Texas
      • Dallas, Texas, United States, 75390-9156
        • UT Southwestern Medical Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 60 years (ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. BMI between 40-60 kg/m2
  2. BMI of 35 kg/m2 with comorbidities

Exclusion Criteria:

  1. large abdominal ventral hernia
  2. large hiatal hernia,
  3. history of liver cirrhosis
  4. history of venous thrombosis or pulmonary embolism, coagulopathy or
  5. Pregnant women

    • All physician, hospital, surgery, and laboratory costs will be billed to the subject or their insurance carriers as customary. The 3.5mm circular stapler is an FDA approved product and it will also be billed to the subject or insurer in the customary fashion.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
ACTIVE_COMPARATOR: Smaller Stapler
3.5 mm Circular Stapler
The procedure consists of a creation of a small gastric pouch and rerouting the small bowel to bypass the stomach and duodenum. There are two anastomoses in this procedure: the gastrojejunostomy and the jejunojejunostomy.
Other Names:
  • Covidien small 3.5 mm Circular Stapler
  • Covidien large 4.8 mm Circular Stapler
ACTIVE_COMPARATOR: Larger Stapler
4.8 mm Circular Stapler
The procedure consists of a creation of a small gastric pouch and rerouting the small bowel to bypass the stomach and duodenum. There are two anastomoses in this procedure: the gastrojejunostomy and the jejunojejunostomy.
Other Names:
  • Covidien small 3.5 mm Circular Stapler
  • Covidien large 4.8 mm Circular Stapler

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Number of Participants With Postoperative Gastrointestinal Hemorrhage
Time Frame: 30 days
30 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2007

Primary Completion (ACTUAL)

April 1, 2009

Study Completion (ACTUAL)

April 1, 2009

Study Registration Dates

First Submitted

October 31, 2005

First Submitted That Met QC Criteria

November 14, 2005

First Posted (ESTIMATE)

November 15, 2005

Study Record Updates

Last Update Posted (ESTIMATE)

February 18, 2010

Last Update Submitted That Met QC Criteria

February 11, 2010

Last Verified

February 1, 2010

More Information

Terms related to this study

Other Study ID Numbers

  • HS 2005 4474
  • SPA 38461

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Morbid Obesity

Clinical Trials on 3.5 mm vs 4.8 mm Stapler During Laparoscopic Gastric Bypass

3
Subscribe